Epidural anesthetic management using ropivacaine in a parturient with multi-minicore disease and susceptibility to malignant hyperthermia.
Saito
Osamu
O
Yamamoto
Tatsuo
T
Mizuno
Yuko
Y
D000328:Adult; D000577:Amides / Q000009:adverse effects / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000008:administration & dosage; D000767:Anesthesia, Epidural / Q000009:adverse effects / Q000379:methods*; D000773:Anesthesia, Obstetrical / Q000379:methods*; D000779:Anesthetics, Local / Q000009:adverse effects / Q000627:therapeutic use*; D004198:Disease Susceptibility; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D006801:Humans; D007751:Labor, Induced / Q000379:methods; D008305:Malignant Hyperthermia / Q000517:prevention & control*; D008991:Monitoring, Physiologic / Q000379:methods; D009123:Muscle Hypotonia / Q000150:complications; D020512:Myopathy, Central Core / Q000150:complications*; D010120:Oxytocics / Q000008:administration & dosage; D010121:Oxytocin / Q000008:administration & dosage; D011247:Pregnancy; D000077212:Ropivacaine
D000577:Amides; D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D010120:Oxytocics; D010121:Oxytocin; D000077212:Ropivacaine; D005283:Fentanyl